Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis

Fig. 5

Bubble plots of meta-regression regarding the HR of ASCT compared with No-ASCT for PFS and OS, according to the induction/consolidation regimens. 1: PFS; 2: OS; A: PI; B: IMiD; C: Combined PI and IMiD; D: Triplet regimen; ASCT, autologous stem-cell transplantation; PI, protease inhibitor; IMiD, immunomodulatory agent; HR, hazard ratio; PFS, progression-free survival; OS, overall survival; * statistical significance

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us